Holliston, MA, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical-stage ...
The DRIVE-RM consortium, led by Professor of Experimental Nephrology Marianne Verhaar from UMC Utrecht, has been awarded €37.5 million under the prestigious NWO SUMMIT program. The SUMMIT grant ...
NEW YORK, NY, TOKYO, JAPAN, March 04, 2025 (GLOBE NEWSWIRE) -- Instinct Brothers Co., Ltd., along with its affiliated entities—Hiroki Global Co., Ltd, Artisans ...
WINSTON-SALEM, N.C. – December 4, 2024 — The Piedmont Triad Regenerative Medicine Engine (PTRME), funded by the National Science Foundation (NSF), has announced a groundbreaking investment of $2.5 ...
Regenerative medicine combines tissue engineering and cell therapies to repair or replace damaged human tissues and organs. Key applications include treating osteoarthritis with mesenchymal stem cells ...
Regenerative medicine has garnered significant attention in recent years for its potential to revolutionize healthcare by harnessing the body's natural healing processes. Among the array of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback